Lv4
428 积分 2025-04-01 加入
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
10个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
10个月前
已完结
Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherin-specific peptides
11个月前
已完结
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors
11个月前
已完结
Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells
11个月前
已完结
Breast cancer prognosis and P-cadherin expression: systematic review and study-level meta-analysis
11个月前
已完结
PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies
11个月前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
1年前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1年前
已完结
In vivo manufacture and manipulation of CAR-T cells for better druggability
1年前
已完结
皖公网安备34019202002308
